Proton or Carbon Ion Therapy for Skull Base Chordoma: Rationale and First Analysis of a Mono-Institutional Experience.
14/03/2023
/
Publications
/
Toxicity
This study reported clinical outcomes of 44 patients treated with proton (89%) or carbon ion therapy (11%). At a median follow-up of 34.3 months, 2-, and 3-year...
The role of combined ion-beam radiotherapy (CIBRT) with protons and carbon ions in a multimodal treatment strategy of inoperable osteosarcoma.
16/06/2021
/
Publications
/
Toxicity
This study reported the outcomes of 20 patients with primary (N=18), metastatic (N=3), or recurrent (N=2) inoperable pelvic (70%) or craniofacial (30%)...
Proton Therapy for Primary Bone Malignancy of the Pelvic and Lumbar Region - Data From the Prospective Registries ProReg and KiProReg.
16/02/2022
/
Publications
/
Toxicity
Eighty-one patients with primary bone malignancy, including Ewing’s sarcoma (58%), chondrosarcoma (7.4%), chordoma (24.7%), osteosarcoma (7.4%), and...
Establishing cost-effective allocation of proton therapy for patients with mediastinal Hodgkin lymphoma
08/08/2021
/
Publications
/
Dosimetry
IMRT
A health-economic study by the Jacksonville group. This study utilized (1) patient-level dosimetric information for a cost-effectiveness analysis using a Markov...
Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to Evidence
08/07/2021
/
Publications
/
Secondary cancer
Consolidative radiation therapy (RT) is of prime importance for early-stage Hodgkin lymphoma (HL) management since it significantly increases progression-free...
Proton Therapy For Lymphomas: Current State Of The Art
01/10/2019
/
Publications
A review of latest development on lymphomas management with proton therapy, including details of proton physic properties, delivery techniques of passive...
Comparing second cancer risk for multiple radiotherapy modalities in survivors of Hodgkin lymphoma
10/04/2021
/
Publications
/
Secondary cancer
VMAT
Using Excess Absolute Risk (EAR) models, this study compared the risk of secondary cancer for Hodgkin lymphoma survivors after either IMRT or PBT radiation...
Clinical IMPT for Hodgkin lymphoma: which patients benefit the most?
01/01/2019
/
Publications
/
Pencil Beam Scanning - PBS
21 HL patients treated with deep inspiration breath-hold pencil-beam scanning (PBS) PT. Normal tissue radiation doses were calculated and compared to doses from...
Proton theraphy for adults with mediastinal lymphomas: The international lymphoma radiation oncology group (ILROG) guidelines.
08/08/2018
/
Publications
Radiation treatment techniques that increase the excess radiation dose to organs at risk (OARs) puts patients at risk of increased side effects, especially late...
Evidence-based Review on the Use of PT in Lymphoma from the PTCOG Lymphoma Subcommittee.
05/09/2017
/
Publications
In an effort to draw attention to the use of proton therapy in lymphoma, and as a resource for future consideration of proton therapy coverage for lymphoma by...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.